Carolinas HealthCare System is pleased to announce that our very own Edward S. Kim, MD, FACP (Levine Cancer Institute) has been selected to Dance with the Stars, presented by Charlotte Ballet.

Preparing to take center stage on March 4, 2017, Dr. Kim and his “dancing shoes” are already wearing down the boards as he logs significant  hours of preparation and practice. A touch competitive by nature, Dr. Kim shows his trademark determination and dedication, and keeps shuffling those graceful feet in his pursuit of dancing perfection.

Unique to this event, proceeds generated from this site will benefit the North Carolina Dance Theatre as well as Carolinas HealthCare System’s Levine Cancer Institute. The event is qualified as an official Carolinas HealthCare System authorized fundraising partnership activity consistent with the guidelines of CHS Partnerships.

You can support Dr. Kim, the North Carolina Dance Theatre and Carolinas HealthCare System by casting your vote via a monetary contribution through this site. For every dollar contributed, an equal number of virtual “votes” is cast in support of Dr. Kim as the top dancing star! Monies generated through this site will be evenly distributed to the designated programs benefiting the North Carolina Dance Theatre and Carolinas Health Care System. Thank you for your interest and support!

Meet the Star…

Edward S. Kim, MD, FACP is Chair of Solid Tumor Oncology and Investigational Therapeutics and the Donald S. Kim Distinguished Chair for Cancer Research at the Levine Cancer Institute, Carolinas HealthCare System in Charlotte, NC. Dr. Kim studies novel targeted agents in the treatment and prevention settings and has expertise in lung, head and neck, as well as thymic cancers. He serves as principal investigator on numerous clinical studies including the Department of Defense Biomarker-based Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) or personalized medicine program in lung cancer. Dr. Kim studies novel targeted agents in the treatment and prevention settings and has expertise in lung, head and neck, as well as thymic cancers.

Dr. Kim is the author or coauthor of more than 100 published articles, book chapters, reviews in journals such as Lancet, Journal of Clinical Oncology, Cancer Discovery, Cancer, and Cancer Prevention Research, involving cancer therapeutics and prevention with chemotherapy and novel targeted agents, with particular emphases on lung cancer and head and neck cancer.